Motif Neurotech
PrivateLast Round
Grant
Jan 20, 2025
Total Funding Raised
$24.75M
Company Overview
Motif Neurotech is a biotechnology company that develops minimally invasive bioelectronic systems for treating treatment-resistant depression through innovative wireless power and data technologies.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Mental Health, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Motif Neurotech Comparables
Compare Motif Neurotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Inner Cosmos | 85% | |
| Starfish Neuroscience | 82% | |
| Cenexum Technologies | 81% |
Motif Neurotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 20, 2025 | ||||
| Series A | Jan 24, 2024 | ||||
| Accelerator | Feb 27, 2023 |
Key People
Founding team and executive leadership
Motif Neurotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Dolby Family Ventures | Series A |
| Arboretum Ventures | Series A |
| re.Mind Capital | Series A |
| Capital Factory | Series A |
| Advanced Research and Invention Agency | Grant |
| Texas Medical Center | Series A |
| Empath Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 14, 2025
Developing a neurostimulator system for severe depression treatment.
- Jan 20, 2025
Secured $6M in grant funding.
Motif Neurotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Motif Neurotech's valuation, stock price, and market status.
Is Motif a public or private company?
Motif is a private company.
What is the current stock price of Motif?
Motif is a private company with no public stock price. No recent secondary market data is available.
How much is Motif worth (valuation)?
Valuation information for Motif is not publicly available.
Can I buy Motif stock?
Motif shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Motif's last funding round?
Motif's most recent funding round was Grant on January 20, 2025.
Who are the main investors in Motif?
Key investors in Motif include Arboretum Ventures.
Will Motif IPO soon?
No public IPO plans have been announced for Motif.
How can I track Motif secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Motif's secondary market activity and sign up for updates.